ST. LOUIS (AP) -- A committee at Washington University did not find sufficient evidence that researcher Timothy Kuklo falsified a study, but said he had violated two school policies in his work.
Kuklo took leave in May and resigned in September after allegations that he inflated data in a study about a bone growth drug used to treat wounded soldiers. He performed the study before coming to Washington University.
Medtronic, the maker of the drug Infuse, had paid Kuklo more than $800,000 in consulting fees over the years.
His lawyer, Henry Dane, said Friday that Kuklo submitted paperwork to the school shortly after arriving in 2006 showing a consulting relationship with Medtronic. The school said the researcher had violated its research integrity and human subject research policies.
(Copyright 2009 by The Associated Press. All Rights Reserved.)